A detailed history of Simplex Trading, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 1,179 shares of MDGL stock, worth $367,848. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,179
Previous 3,572 66.99%
Holding current value
$367,848
Previous $1 Million 75.0%
% of portfolio
0.01%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$212.22 - $292.96 $507,842 - $701,053
-2,393 Reduced 66.99%
1,179 $250,000
Q2 2024

Jul 25, 2024

BUY
$193.33 - $291.99 $575,930 - $869,838
2,979 Added 502.36%
3,572 $1 Million
Q1 2024

Apr 25, 2024

SELL
$171.37 - $283.23 $572,547 - $946,271
-3,341 Reduced 84.93%
593 $158,000
Q4 2023

Feb 02, 2024

SELL
$120.4 - $237.13 $204,920 - $403,595
-1,702 Reduced 30.2%
3,934 $910,000
Q3 2023

Nov 01, 2023

SELL
$146.04 - $225.78 $2.48 Million - $3.84 Million
-17,006 Reduced 75.11%
5,636 $823,000
Q2 2023

Aug 04, 2023

BUY
$203.88 - $312.0 $2.1 Million - $3.21 Million
10,278 Added 83.13%
22,642 $5.23 Million
Q1 2023

Apr 27, 2023

BUY
$231.06 - $307.08 $2.86 Million - $3.8 Million
12,364 New
12,364 $3 Million
Q3 2022

Nov 04, 2022

SELL
$60.57 - $79.51 $33,737 - $44,287
-557 Reduced 10.3%
4,850 $315,000
Q2 2022

Aug 03, 2022

SELL
$58.04 - $100.2 $291,012 - $502,402
-5,014 Reduced 48.11%
5,407 $387,000
Q1 2022

May 02, 2022

BUY
$55.89 - $101.89 $311,363 - $567,629
5,571 Added 114.87%
10,421 $1.02 Million
Q4 2021

Feb 23, 2022

SELL
$72.34 - $95.09 $822,071 - $1.08 Million
-11,364 Reduced 70.09%
4,850 $410,000
Q3 2021

Oct 28, 2021

BUY
$78.35 - $105.02 $3,995 - $5,356
51 Added 0.32%
16,214 $1.61 Million
Q2 2021

Aug 12, 2021

BUY
$97.2 - $137.59 $1.1 Million - $1.56 Million
11,313 Added 233.26%
16,163 $1.57 Million
Q4 2020

Feb 02, 2021

SELL
$110.06 - $133.7 $521,574 - $633,604
-4,739 Reduced 49.42%
4,850 $539,000
Q3 2020

Oct 14, 2020

SELL
$99.78 - $124.21 $2.03 Million - $2.53 Million
-20,347 Reduced 67.97%
9,589 $1.14 Million
Q2 2020

Jul 13, 2020

BUY
$60.13 - $125.71 $278,822 - $582,917
4,637 Added 18.33%
29,936 $3.39 Million
Q1 2020

Apr 29, 2020

BUY
$66.76 - $93.49 $1.15 Million - $1.6 Million
17,158 Added 210.76%
25,299 $1.69 Million
Q4 2019

Feb 05, 2020

BUY
$84.28 - $118.5 $91,359 - $128,454
1,084 Added 15.36%
8,141 $741,000
Q3 2019

Oct 15, 2019

BUY
$84.4 - $106.53 $58,911 - $74,357
698 Added 10.98%
7,057 $608,000
Q2 2019

Jul 26, 2019

BUY
$91.13 - $142.5 $233,019 - $364,372
2,557 Added 67.25%
6,359 $666,000
Q1 2019

Apr 18, 2019

SELL
$103.48 - $143.84 $517 - $719
-5 Reduced 0.13%
3,802 $0
Q4 2018

Jan 16, 2019

BUY
$94.77 - $215.54 $257,963 - $586,699
2,722 Added 250.88%
3,807 $429,000
Q3 2018

Oct 23, 2018

BUY
$207.3 - $300.31 $224,920 - $325,836
1,085 New
1,085 $232,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.34B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.